NCT00500812View on ClinicalTrials.gov

A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

February 28, 2009

Conditions
Spinal Cord Injury
Interventions
DRUG

Cethrin

Trial Locations (8)

19107

Thomas Jefferson University Hospital, Philadelphia

22908

Univ.of Virginia Health System, Charlottesville

45267

University of Cincinnati Mayfield Clinic and Spine Institute, Cincinnati

85013

St. Joseph's Hospital & Medical Center, Phoenix

98104

University of Washington Harborview Medical Center, Seattle

M4N3M5

Sunnybrooke Health Sciences Centre, Toronto

M5T2S8

Toronto Western Hospital, Toronto

H4J1C5

Hopital du Sacre-Coeur de Montreal, Montreal

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT00500812 - A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries | Biotech Hunter | Biotech Hunter